{
    "2019-08-05": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Aduro (ADRO) Earnings Miss in Q2, Revenues Meet Estimates",
                "features": {
                    "keywords": [
                        "Earnings Miss",
                        "Revenues Meet",
                        "Q2"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Dividend Stock",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Corcept's (CORT) Earnings & Revenues Miss Estimates in Q2",
                "features": {
                    "keywords": [
                        "Earnings Miss",
                        "Revenues Miss",
                        "Q2"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Eli Lilly Announces Positive Results For Emgality",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Positive Results",
                        "Emgality"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Lilly Announces Positive Results for EmgalityÂ® (galcanezumab-gnlm) from the CONQUER Study in Patients who Failed Previous Migraine Preventive Treatments",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Positive Results",
                        "Emgality",
                        "CONQUER Study"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}